Paxman ABPXMBF 77 Shareholder Yield % is 0.19% as of Mar. 2026. GuruFocus rates PXMBF with a GF Score™ of 77/100 and a GF Value™ of $4.38. The stock has 3 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Paxman AB ranks better than 50.67% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Paxman AB's Shareholder Yield % was 0.19%.
Paxman AB (OTCPK:PXMBF) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Paxman AB Shareholder Yield % Related Terms
Paxman AB Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for Paxman AB's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PXMBF vs ABT, SYK, MDT: Shareholder Yield % Comparison
For the Medical Devices subindustry, Paxman AB's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paxman AB Shareholder Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paxman AB's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Paxman AB's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Paxman AB (PXMBF) has a Shareholder Yield % of 0.19% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Paxman AB and its competitors. According to the industry distribution chart, Paxman AB ranks #403 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 49.3%.
Is Paxman AB's Shareholder Yield % too high?
Paxman AB's current Shareholder Yield % is 0.19%. The Medical Devices & Instruments industry median Shareholder Yield % is 0.14. Paxman AB's value of 0.19% is 35.7% above this industry median. Based on the distribution chart, Paxman AB ranks #403 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Paxman AB has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Paxman AB's Shareholder Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Paxman AB ranks #403 out of 817 companies for Shareholder Yield %. This puts Paxman AB in the upper half of its industry. The industry median Shareholder Yield % is 0.14. Paxman AB's value of 0.19% is 35.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Devices & Instruments company?
The median Shareholder Yield % among Medical Devices & Instruments companies is 0.14, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paxman AB's current Shareholder Yield % of 0.19% is 35.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Paxman AB and its competitors. For the Medical Devices & Instruments industry, the median Shareholder Yield % is 0.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paxman AB's current Shareholder Yield % is 0.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paxman AB stock overvalued right now?
Paxman AB (PXMBF) has a current Shareholder Yield % of 0.19%. The stock's GF Value™ is $4.38, compared to a current price of $3.50 — trading 20.1% below its estimated fair value. The current Shareholder Yield % is 0.19% and 35.7% above the Medical Devices & Instruments industry median of 0.14. Paxman AB's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Paxman AB (PXMBF), the current Shareholder Yield % is 0.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paxman AB (PXMBF) Overvalued in 2026?
Based on GuruFocus' analysis, Paxman AB stock appears to be undervalued.
The current stock price of $3.50 is trading 20.1% below its estimated GF Value™ of $4.38.
Key valuation signals for PXMBF:
Shareholder Yield %: 0.19%
GF Value™: $4.38 vs. price of $3.50 (20.1% below fair value)
Industry Position: 35.7% above the Medical Devices & Instruments median (#403 of 817)
No single metric tells the full story. See the PXMBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paxman AB is a Sweden-based company engaged in the development of the PAXMAN Scalp Cooling System, which has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The portfolio includes both the Paxman and Digni Capsystems with several installations in hospitals, clinics, and treatment centres world-wide.
77GF Score
Get the complete analysis for PXMBF
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PXMBF has been successfully added to your 
